PortfoliosLab logoPortfoliosLab logo
SMG vs. JAZZ
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

SMG vs. JAZZ - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in The Scotts Miracle-Gro Company (SMG) and Jazz Pharmaceuticals plc (JAZZ). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, SMG achieves a 11.08% return, which is significantly lower than JAZZ's 35.44% return. Over the past 10 years, SMG has underperformed JAZZ with an annualized return of 2.73%, while JAZZ has yielded a comparatively higher 5.26% annualized return.


SMG

1D
1.24%
1M
7.32%
YTD
11.08%
6M
11.01%
1Y
4.51%
3Y*
8.00%
5Y*
-16.76%
10Y*
2.73%

JAZZ

1D
1.92%
1M
-3.99%
YTD
35.44%
6M
35.86%
1Y
115.67%
3Y*
22.63%
5Y*
5.19%
10Y*
5.26%
*Multi-year figures are annualized to reflect compound growth (CAGR)

SMG vs. JAZZ - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
SMG
The Scotts Miracle-Gro Company
11.08%-8.01%8.28%36.92%-68.81%-18.03%96.18%77.05%-41.00%14.46%
JAZZ
Jazz Pharmaceuticals plc
35.44%38.04%0.12%-22.79%25.05%-22.81%10.56%20.43%-7.94%23.50%

Correlation

The correlation between SMG and JAZZ is 0.18, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.18

Correlation (3Y)
Calculated over the trailing 3-year period

0.26

Correlation (5Y)
Calculated over the trailing 5-year period

0.27

Correlation (10Y)
Calculated over the trailing 10-year period

0.25

Correlation (All Time)
Calculated using the full available price history since Jun 1, 2007

0.25

Fundamentals

Market Cap

SMG:

$3.75B

JAZZ:

$15.22B

EPS

SMG:

$1.90

JAZZ:

$0.47

PE Ratio

SMG:

33.39

JAZZ:

487.71

PEG Ratio

SMG:

0.23

JAZZ:

31.70

PS Ratio

SMG:

1.09

JAZZ:

3.24

Total Revenue (TTM)

SMG:

$3.39B

JAZZ:

$4.44B

Gross Profit (TTM)

SMG:

$1.10B

JAZZ:

$2.97B

EBITDA (TTM)

SMG:

$493.90M

JAZZ:

$336.83M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

SMG vs. JAZZ — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SMG
SMG Risk / Return Rank: 4545
Overall Rank
SMG Sharpe Ratio Rank: 4747
Sharpe Ratio Rank
SMG Sortino Ratio Rank: 4141
Sortino Ratio Rank
SMG Omega Ratio Rank: 4141
Omega Ratio Rank
SMG Calmar Ratio Rank: 4747
Calmar Ratio Rank
SMG Martin Ratio Rank: 4646
Martin Ratio Rank

JAZZ
JAZZ Risk / Return Rank: 9797
Overall Rank
JAZZ Sharpe Ratio Rank: 9696
Sharpe Ratio Rank
JAZZ Sortino Ratio Rank: 9797
Sortino Ratio Rank
JAZZ Omega Ratio Rank: 9696
Omega Ratio Rank
JAZZ Calmar Ratio Rank: 9898
Calmar Ratio Rank
JAZZ Martin Ratio Rank: 9797
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

SMG vs. JAZZ - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for The Scotts Miracle-Gro Company (SMG) and Jazz Pharmaceuticals plc (JAZZ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


SMGJAZZDifference
Sharpe ratioReturn per unit of total volatility

-3.00

Sortino ratioReturn per unit of downside risk

-4.27

Omega ratioGain probability vs. loss probability

1.05

1.59

-0.54

Calmar ratioReturn relative to maximum drawdown

0.19

10.19

-10.00

Martin ratioReturn relative to average drawdown

0.34

25.34

-25.00

SMG vs. JAZZ - Sharpe Ratio Comparison

The current SMG Sharpe Ratio is 0.13, which is lower than the JAZZ Sharpe Ratio of 3.13. The chart below compares the historical Sharpe Ratios of SMG and JAZZ, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

SMG vs. JAZZ - Drawdown Comparison

The maximum SMG drawdown since its inception was -83.55%, smaller than the maximum JAZZ drawdown of -96.90%. Use the drawdown chart below to compare losses from any high point for SMG and JAZZ.


Loading charts...

Drawdown Indicators


SMGJAZZDifference

Max Drawdown

Largest peak-to-trough decline

-83.55%

-96.90%

+13.35%

Max Drawdown (1Y)

Largest decline over 1 year

-23.85%

-11.42%

-12.43%

Max Drawdown (3Y)

Largest decline over 3 years

-47.42%

-32.71%

-14.71%

Max Drawdown (5Y)

Largest decline over 5 years

-78.41%

-47.09%

-31.32%

Max Drawdown (10Y)

Largest decline over 10 years

-83.55%

-52.10%

-31.45%

Current Drawdown

Current decline from peak

-69.55%

-4.09%

-65.46%

Average Drawdown

Average peak-to-trough decline

-22.04%

-27.35%

+5.31%

Ulcer Index

Depth and duration of drawdowns from previous peaks

13.31%

4.58%

+8.73%

Volatility

SMG vs. JAZZ - Volatility Comparison

The Scotts Miracle-Gro Company (SMG) has a higher volatility of 10.03% compared to Jazz Pharmaceuticals plc (JAZZ) at 8.10%. This indicates that SMG's price experiences larger fluctuations and is considered to be riskier than JAZZ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


SMGJAZZDifference

Volatility (1M)

Calculated over the trailing 1-month period

10.03%

8.10%

+1.93%

Volatility (6M)

Calculated over the trailing 6-month period

26.49%

23.46%

+3.03%

Volatility (1Y)

Calculated over the trailing 1-year period

34.25%

37.15%

-2.90%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

46.34%

31.84%

+14.50%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

40.43%

32.77%

+7.66%

Dividends

SMG vs. JAZZ - Dividend Comparison

SMG's dividend yield for the trailing twelve months is around 4.16%, while JAZZ has not paid dividends to shareholders.


PositionTTM20252024202320222021202020192018201720162015
JAZZ
Jazz Pharmaceuticals plc
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
SMG
The Scotts Miracle-Gro Company
4.16%4.52%3.98%4.14%5.43%1.59%3.72%2.13%3.51%1.93%2.03%2.85%

Financials

SMG vs. JAZZ - Financials Comparison

This section allows you to compare key financial metrics between The Scotts Miracle-Gro Company and Jazz Pharmaceuticals plc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


500.00M1.00B1.50B2.00B20222023202420252026
1.46B
1.07B
(SMG) Total Revenue
(JAZZ) Total Revenue
Values in USD except per share items

SMG vs. JAZZ - Profitability Comparison

The chart below illustrates the profitability comparison between The Scotts Miracle-Gro Company and Jazz Pharmaceuticals plc over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

-20.0%0.0%20.0%40.0%60.0%80.0%100.0%20222023202420252026
41.8%
0
Portfolio components
SMG - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, The Scotts Miracle-Gro Company reported a gross profit of 610.50M and revenue of 1.46B. Therefore, the gross margin over that period was 41.8%.

JAZZ - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Jazz Pharmaceuticals plc reported a gross profit of 0.00 and revenue of 1.07B. Therefore, the gross margin over that period was 0.0%.

SMG - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, The Scotts Miracle-Gro Company reported an operating income of 401.80M and revenue of 1.46B, resulting in an operating margin of 27.5%.

JAZZ - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Jazz Pharmaceuticals plc reported an operating income of 336.60M and revenue of 1.07B, resulting in an operating margin of 31.5%.

SMG - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, The Scotts Miracle-Gro Company reported a net income of 238.60M and revenue of 1.46B, resulting in a net margin of 16.4%.

JAZZ - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Jazz Pharmaceuticals plc reported a net income of 293.10M and revenue of 1.07B, resulting in a net margin of 27.4%.


Frequently Asked Questions


SMG and JAZZ have a correlation of 0.18, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

SMG has higher volatility (10.03%) compared to JAZZ (8.10%). In terms of maximum drawdown, SMG dropped -83.55% vs JAZZ's -96.90%.

JAZZ currently has the higher Sharpe Ratio (3.13 vs 0.13), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for SMG and JAZZ

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer